Artrya Limited (ASX:AYA) Receives FDA Clearance for Salix® Coronary Plaque Module
Artrya Limited (ASX:AYA) receives FDA clearance for Salix® Coronary Plaque module, expanding its U.S. commercial opportunities.
Tag: Regulatory News & Compliance
Telix Pharmaceuticals (ASX:TLX) Reports Strong H1 2025 Results
Telix Pharmaceuticals (ASX:TLX) reports a 63% revenue increase in H1 2025, maintaining strong financial and operational growth.
Xamble Group Limited (ASX:XGL) Announces Entitlement Offer
Xamble Group Limited (ASX:XGL) launches a renounceable entitlement offer to raise up to A$1.35M through the issuance of CDIs and options.
Monash IVF Group Limited (ASX:MVF) Completes Independent Review of Clinic Incidents
Monash IVF Group Limited (ASX:MVF) finalises independent review of Brisbane and Clayton incidents, enhancing patient safety measures.
TPG Telecom Limited (ASX:TPG) Announces Investigation into iiNet Cyber Incident
TPG Telecom (ASX:TPG) investigates a cyber incident affecting iiNet order management system, with no evidence of broader impact.
Xstate Resources Limited (ASX:XST) Extends Public Offer Period for ASX Re-admission
Xstate Resources (ASX:XST) extends its public offer period to raise $2 million, aiming for ASX Official List re-admission.
ASX Limited (ASX:ASX) Announces Increased Operating Expenses Due to ASIC Inquiry
ASX Limited (ASX:ASX) expects a $25-35 million rise in FY26 operating expenses due to ASIC Inquiry, reaffirming its strategic commitments.
The Star Entertainment Group (ASX:SGR) Extends $5,000 Daily Cash Limit Until 2027
The Star Entertainment Group (ASX:SGR) secures an extension for the $5,000 daily cash limit for gaming customers until August 2027.
TPG Telecom Limited (ASX:TPG) Receives ‘BBB’ Rating from S&P Global
TPG Telecom Limited (ASX:TPG) is assigned a ‘BBB’ rating by S&P Global, highlighting its capital management initiatives and debt reduction plans.
PYC Therapeutics (ASX:PYC) Releases Q2 2025 Shareholder Update
PYC Therapeutics (ASX:PYC) updates shareholders on significant clinical progress and a strong financial position in Q2 2025.